Abstract
Neurodevelopmental disorders like Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS) often share similar behavioral and cognitive traits, which can make diagnosis and treatment more complex. While ASD typically arises from a mix of genetic and environmental influences, FXS is directly linked to mutations in the FMR1 gene. This review highlights recent progress in the use of neuroimaging—especially functional MRI (fMRI)—and machine learning, both of which are playing a growing role in improving diagnostic accuracy and deepening our understanding of how the brain functions in ASD and FXS. By exploring the latest research, we show how these tools help uncover both unique and overlapping patterns in brain activity, laying the groundwork for earlier diagnosis and more personalized interventions. These developments point to the powerful potential of combining brain imaging and AI to transform the way we approach diagnosis and care. Continued collaboration across disciplines is key to refining these techniques and moving closer to precision medicine in the field of neurodevelopmental disorders.
Keywords
Autism Spectrum Disorder, Fragile X Syndrome, Neurodevelopmental Disorders, Neuroimaging, Functional Magnetic Resonance Imaging, Machine Learning, Brain Connectivity, Early Detection
INTRODUCTION
Autism Spectrum Disorder probably represents the most complex neurodevelopmental disorder characterized by persistent impairment in social communication and interaction and restricted, repetitive patterns of behavior, interests, or activities. It is a spectrum disorder because it encompasses a wide range from mild to severe along the continuum. While some individuals may exhibit mild social challenges, others experience profound impairments in communication and daily functioning. These challenges often emerge early in development, with affected individuals displaying delayed language acquisition, difficulties in social reciprocity, and heightened sensitivity to sensory stimuliASD also more often than not overlaps with other neurodevelopmental disorders such as intellectual disability, attention deficit/hyperactivity disorder, and epilepsy, making the diagnosis and management of ASD even more complicated. The origin of ASD is yet unknown, but there are indications for a multi-factorial occurrence through factors stemming from genetic to environmental causes.Advances in genetic research have identified several genes associated with ASD, many of which are involved in synaptic function, chromatin remodeling, and neural development. However, ASD is thought to be polygenic, with multiple genes and variants contributing to the risk of developing the disorder. Environmental factors, including prenatal exposures and birth complications, are also believed to play a significant role in increasing ASD risk. Despite these advances, the biological mechanisms underlying ASD remain a subject of ongoing investigation, with researchers focusing on how these genetic and environmental factors interact during early brain development.Neuroimaging studies have provided valuable insights into the atypical brain development associated with ASD. Altered patterns of brain connectivity, including both hypo- and hyper-connectivity between key neural circuits, have been observed in individuals with ASD. These disruptions are particularly evident in regions responsible for social cognition, communication, and sensory processing. Additionally, research suggests that these neural abnormalities can emerge in infancy, offering critical opportunities for early detection and intervention. However, the heterogeneity of ASD presents significant challenges, as the degree and nature of brain connectivity changes can vary widely among individuals, highlighting the need for personalized diagnostic and therapeutic approaches.
FXS is not only the most common inherited cause of intellectual disability but also one of the major genetic contributors to neurodevelopmental disorders. This genetic disorder results from a mutation in the FMR1 gene, which is located on the X chromosome. In normal individuals, the gene encodes for the Fragile X Mental Retardation Protein, FMRP, which, among many roles, modulates synaptic plasticity—a process at the heart of learning and memory. In individuals with FXS, the FMR1 gene has a trinucleotide repeat expansion that leads to the gene's silencing and to either the absence or a severe reduction of FMRP. The loss of this protein disrupts synaptic functioning, leading to the hallmark features associated with FXS: intellectual disability, social anxiety, speech and language delays, and repetitive behaviors. The majority of those with FXS are males because their symptoms obviously manifest from having a single "X" chromosome. Females with FXS may experience a milder phenotype due to the presence of a second, typically functioning X chromosome. Cognitive impairments in individuals with FXS range from mild to severe, with many individuals displaying developmental delays in language and motor skills during early childhood. Behavioral characteristics such as hyperactivity, attention deficits, and heightened social anxiety are common in FXS, making it challenging for affected individuals to navigate social environments. Physical features, such as elongated faces, large ears, and hyperextensible joints, may also be present, although these are not diagnostic indicators of the syndrome.While FXS is a single-gene disorder, the clinical presentation is highly variable, with some individuals exhibiting significant social and behavioral challenges that overlap with other neurodevelopmental conditions, particularly Autism Spectrum Disorder (ASD). This overlap has become a focal point for researchers investigating the neurobiological mechanisms that connect these two conditions. Moreover, the absence of FMRP in FXS leads to abnormalities in neural signaling pathways, particularly in synaptic functioning, which may contribute to the cognitive and behavioral features observed in both FXS and ASD.
The relationship between Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS) represents a critical area of inquiry within neurodevelopmental research, primarily due to the notable overlap in behavioral characteristics exhibited by individuals with both conditions. It is estimated that approximately 50-75 % of individuals diagnosed with FXS display traits consistent with autism, thereby positioning FXS as the most prevalent single-gene cause of ASD. This intersection underscores the importance of understanding how these two conditions coalesce, particularly regarding their shared challenges such as impairments in social communication, repetitive behaviors, and sensory sensitivities.The overlapping symptomatology between ASD and FXS can complicate the diagnostic landscape, particularly in cases where individuals with FXS may be misdiagnosed with idiopathic ASD. This misdiagnosis often occurs when comprehensive genetic evaluations are not conducted, highlighting the necessity for thorough assessments in clinical practice. At the genetic level, FXS is characterized by the absence or reduction of the Fragile X Mental Retardation Protein (FMRP), a crucial protein involved in synaptic plasticity. The loss of FMRP disrupts synaptic function and brain development, resulting in behavioral manifestations that parallel some features of ASD. The synaptic dysregulation observed in FXS provides a potential framework for exploring the neurobiological underpinnings shared with idiopathic ASD. Indeed, impaired synaptic signaling has been implicated in both conditions, suggesting a common pathway contributing to social communication deficits and repetitive behaviors.Clinical observations indicate that individuals with both FXS and ASD tend to experience more severe manifestations of symptoms, particularly in areas of communication and repetitive behaviors, compared to those with FXS alone. This overlap in symptoms can obscure the identification of distinct neurobiological differences between the two conditions, emphasizing the urgent need for refined diagnostic tools. Such tools could accurately differentiate FXS-related ASD from idiopathic ASD, ensuring that treatments are tailored to meet the unique needs of individuals with either or both conditions. Moreover, examining ASD within the context of FXS can provide critical insights into broader mechanisms associated with ASD, especially concerning synaptic development and plasticity. Individuals exhibiting both FXS and ASD frequently present with pronounced social communication deficits and heightened sensory sensitivities. Common challenges faced by these individuals include difficulties with eye contact, delays in language acquisition, and increased social anxiety. Sensory issues, such as aversions to specific textures, sounds, or lighting conditions, can exacerbate difficulties in social interactions, often leading to greater behavioral rigidity and social isolation. Neuroimaging studies have revealed distinctive patterns of brain connectivity in individuals diagnosed with both ASD and FXS, particularly in regions associated with social cognition and communication. Atypical functional connectivity likely stems from the absence of FMRP and the consequent synaptic abnormalities, reinforcing the need for targeted research into these neural patterns. By pinpointing specific brain circuits that contribute to autistic traits in the context of FXS, researchers aim to differentiate these mechanisms from those observed in idiopathic ASD. Ultimately, the findings derived from studying the intersection of ASD and FXS are crucial for developing interventions tailored to address the dual challenges faced by individuals with both conditions. Through deeper understanding of the neurobiological and genetic foundations shared by ASD and FXS, researchers can inform the design of more effective therapeutic strategies that account for the unique profiles of individuals affected by these neurodevelopmental disorder.(5)
METHODS
Deep Neural Network
The DNN is a type of computational model that contains various layers of interrelated elements or neurons, which process data information inspired by the structure of the human brain. It has an input layer, multiple hidden layers, and an output layer; each layer in this architecture transforms the data to pass to the next one. Such steps allow DNNs to understand complex patterns within the data by the adjustment of weights from the connections themselves, a process called backpropagation, which minimizes the error of prediction. Faria Zarin Subah et al. used functional connectivity features from pre-processed fMRI data for the detection of autism spectrum disorder. The time-series signals from the brain regions of interest were extracted and then transformed into FC matrices. The FC matrices were used to perform the classification between ASD and controls using a deep neural network.
Support Vector Machine
The Support Vector Machine is a supervised learning algorithm used for classification and regression purposes. It works through the construction of an optimal hyperplane that maximally separates data points of different classes in feature space to maximize the margin between data points from the hyperplane a better generalization for new data. Therefore, the support vector machine can adopt a different kernel function, such as linear, polynomial, and radial, to handle nonlinear data by transforming it into a higher dimensional space where classes become separable. Yaya Liu et al.(7) analyzedrs-fMRI data from 1,054 subjects (506 ASD, 548 control) from the ABIDE database, constructing individual brain networks with functional connectivity matrices. Using Extra-Trees, they reduced high-dimensional features from 19,900 to a focused set, applying cross-validation to ensure reliable classification results across sites. Meijie Liu et al.(8) aimed to improve ASD classification using machine learning models, including deep learning and SVMs, with advanced feature selection techniques. They focused on high classification accuracy to identify potential biomarkers for ASD, with deep learning outperforming traditional methods. Sjir J. C. Schielenet al.(9) systematically reviewed and compared cross-sectional studies that use machine learning to classify ASD via resting-state MRI data. They evaluated models like SVM and NN across different imaging modalities and performed a meta-analysis to identify approaches yielding the best sensitivity and specificity for ASD classification. Hong Li et al.(10) aimed to classify children with ASD using resting-state fMRI data, involving 71 children with ASD. They calculated key metrics like the Autonomy Index (AI) and Connectivity Functional Homotopy (CFH) to assess inter-hemispheric brain connectivity, with the goal of enhancing diagnostic accuracy by understanding brain connectivity patterns in ASD. Sathish et al.(11) introduced a method to predict ASD behaviors using fMRI data by calculating functional connectivity and constructing complex networks. The features were clustered and classified using SVM, aiming for high classification accuracy to improve early ASD diagnosis. An evolutionary algorithm was used to refine voxel selection for better predictive performance. Xin Yang et al.(12) proposed a machine learning approach to analyzers-fMRI data for classifying individuals with ASD. Using a dataset of 871 samples, they compared classifiers like logistic regression, SVM, and DNN. The DNN, with eight hidden layers and regularization, aimed to improve classification accuracy and identify objective biomarkers from neuroimaging data. Zhao F et al.(13) proposed constructing low-order and multi-level high-order functional connectivity networks from rs-fMRI data to capture brain interactions. Features were refined using LASSO for selection, and SVM classifiers were trained on the selected features, utilizing an ensemble of models for improved performance in ASD classification. Knoth et al.(33) applied SVM to predict cognitive functioning levels in participants with Fragile X Syndrome (FXS) using single-trial repetition suppression features derived from EEG data. They conducted a binary classification to differentiate between FXS participants with Non-Verbal Intelligence Quotient (NVIQ) scores ≤ 42 and those with scores > 42. The classification here was based on the differences in energies between the first presentation-P1 and subsequent presentations, and between the second presentation-P2 and later presentations to capture intrinsic repetition effects in the data. Additionally, a leave-two-subject-out cross-validation scheme was implemented, ensuring a strict separation of participants during both training and testing phases, hence increasing the validity of the findings. Therefore, the high decoding accuracy of more than 65 % due to the classification performed using the SVM was statistically significant, and hence the single-trial repetition suppression features were used as sensitive biomarkers for cognitive functioning in subjects with FXS. Fumiko Hoeft et al.(34) carried out linear SVM analyses on subjects with fragile X syndrome and idiopathic autism along with control groups to identify neuroanatomical differences among these groups. They employed SVM for the automatic classification of the subjects according to the regional pattern of GMV and WMV and identified anatomic brain regions in which the groups significantly differed. Neuroimaging data were preprocessed using PCA for the dimensionality reduction; after that, RFE-SVM was used for choosing the most informative voxels for classification. This approach allowed to discern distinct brain patterns associated with FXS and iAUT, providing insights into the underlying neuroanatomical variations. Furthermore, SVM was also employed on behavioral data to determine if differences between the groups could be detected through behavioral measures alone, further underscoring the versatility and efficacy of SVM in analyzing complex neuroimaging data.
Auto Encoder
The autoencoder is a neural network designed for unsupervised learning, with its purpose being to achieve feature dimensionality reduction by learning an efficient, compressed representation of data in a manner similar to PCA. Fully autoencoders consist of two parts: one part is an encoder, which maps input data to a lower-dimensional space, and the other part is a decoder, which reconstructs the original data from this compressed form. Autoencoders often find applications in feature extraction, noise reduction, and anomaly detection. In this respect, Taban Eslami et al.(14) employed an SLP with an auto-encoder in order to classify ASD from fMRI images. The autoencoder reduced brain connectivity feature dimensionality, while SMOTE-inspired data augmentation generated synthetic samples to enhance model performance and generalizability. Fahad Almuqhim and Fahad Saeed (15) utilized resting-state fMRI data to classify ASD by applying a Sparse Autoencoder to reduce input dimensionality from 9 500 to 4 975 features. These features were then classified using a Deep Neural Network, with k-fold cross-validation employed to improve robustness against overfitting. Yuqing Song et al.(16) analyzed resting-state fMRI data from the ABIDE dataset to classify ASD, using a Sparse Autoencoder to reduce dimensionality and retain key features. These were then classified with a Deep Neural Network, incorporating community detection metrics to assess brain connectivity, and employing k-fold cross-validation for reliability.
Polygenic Risk Score Model
Although a PRS model quantifies the predisposition of an individual to a particular trait or disorder, it is conceived based on the cumulative effects of multiple genetic variants. By aggregating the effects of many single nucleotide polymorphisms, SNPs provide a numerical score reflecting liability for conditions like ASD, heart disease, or other traits. This will also contribute to early risk assessment, personalized medicine, and the elucidation of the genetic architecture of complex diseases. Tingting Luo et al.(17) combined genetic and neuroimaging data to enhance the understanding and classification of ASD. They calculated polygenic risk scores (PRS) from whole exome sequencing (WES) to assess genetic predisposition and used MRI data to construct brain connectivity networks. The aim was to integrate these findings to improve diagnosis and differentiate ASD cases based on genetic and brain structural features.
Bayesian Network
A Bayesian network is a probabilistic graphical model—a representation of a set of variables and their dependencies via the structure of a directed acyclic graph. In the network, each node corresponds to a variable, while the edges represent conditional dependencies between them. Bayesian networks allow reasoning out of uncertainty for efficacious inference and decision-making upon prior knowledge and observed data. They find typical applications in genetics, medical diagnosis, and several tasks in machine learning, like classification and prediction. Yongxia Zhou et al.(18) suggested a data-driven approach to classify ASD by considering fMRI data, integrating multi-parametric imaging analysis such as volumetric and functional connectivity measures. This work improves on diagnostic accuracy and correlation of imaging features with clinical data through advanced feature selection strategies and several machine learning classifiers, enhancing the understanding of ASD biomarkers and hence facilitating their early diagnosis.
Recursive Feature Elimination
RFE is a feature selection method that enables one to identify the most important variables in any given dataset. It works by recursively fitting a model, removing features identified as the least significant according to the performance of the model, usually measured with the metrics of accuracy or mean squared error. RFE enhances model interpretability, reduces overfitting, and improves computational efficiency by focusing on a small subset of relevant features. It can be applied with variants of machine learning algorithms, such as support vector machines or linear regressions, for optimizing model performance. N. Chaitra et al.(19) proposed a method for the classification of ASD by using functional Magnetic Resonance Imaging data with emphasis on FC and complex network analysis. The authors have derived a variety of graph-theoretic features from connectivity matrices to quantify brain function. This will enhance the diagnostic accuracy by using relevant features selected through statistical testing, thereby enhancing its capability for understanding the biomarkers of ASD in order to carry out early diagnosis.
Multilayer Perceptron
A multilayer perceptron (MLP) is a type of artificial neural network that consists of multiple layers of interconnected nodes, or neurons, including an input layer, one or more hidden layers, and an output layer. MLPs use a supervised learning technique called backpropagation to adjust weights based on the error between predicted and actual outputs, enabling them to learn complex functions. They are capable of solving a wide range of problems, including classification and regression tasks, and can model non-linear relationships in data. Taban Eslami and Fahad Saeed (20) proposed a deep learning model for classifying autism spectrum disorder (ASD) that utilizes a multilayer perceptron trained on functional connectivity data. To tackle data scarcity, the model employs SMOTE for oversampling, generating synthetic samples to enhance training. Hyperparameter tuning is conducted using Auto-Tuned Models (ATM) to optimize SVM classifiers combined with the MLP, improving classification accuracy through effective feature extraction and model selection.
Deep Reinforcement Learning
Deep reinforcement learning is a strategy that amalgamates reinforcement learning with deep learning to enable an agent to learn an optimum behavior through interaction with an environment. In DRL, deep neural networks are used for approximating value functions or policies, hence allowing an agent to process high-dimensional state spaces given as images or complex data. Through the process, this agent learns to maximize cumulative rewards either through feedback in the form of immediate rewards or penalties. Joseph Stember et al.(21) developed classifiers that differentiate autism spectrum disorder from neurotypical controls based on the fMRI data from the ABIDE database. It used the architecture of DQN for DRL and GNN for SDL, both trained on the incidence matrices of brain connectivity. In the DRL model, a scalar is assigned for the correctness of each prediction to strengthen the learning, while the SDL model optimizes its classification accuracy with traditional supervised methods.
Principal Component Analysis
PCA is a statistical approach that reduces dimensionality while preserving the variation in a set of data. The method transforms original variables into a new set of uncorrelated variables, called principal components, each ordered by the amount of variation from the data they catch. It simplifies datasets so that data visualization can easily take place and analysis can be carried out, while noise and redundancy are minimized. It finds broad applications in fields related to data analysis, machine learning, and image processing, mainly for performance enhancement and interpretability. YuMei Duan et al.(22) extracted features from fMRI data using a spherical searchlight approach. The authors then applied PCA to reduce dimensionality by retaining 80 % of the variance. Classification was performed by SVM, and accuracy was calculated using 5-fold cross-validation. Thus, the "virtual lesion" analysis was also included in the study to measure individual contributions of brain regions in model predictions that investigate the relation between structural brain changes and clinical severity of ASD.
Conventional Neural Network
Convolutional Neural Networks represent a class of deep learning models designed for structured grid data, such as images. They use convolutional layers that apply filters to input data, giving the network the capability to automatically learn spatial hierarchies of features from the input data; these include edges and textures. They exhibit outstanding performance in classic applications like object detection, image segmentation, and image classification, far outperforming traditional approaches. The Rajat Mani Thomas et al.(23) classification model used a 3D-CNN architecture on resting-state fMRI images transformed into nine summary measures related to different features of interest. Five-fold cross-validation and leave-site-out cross-validation showed the best performance when an ensemble strategy combined those summary measures; however, poor generalization performance was turned out on new sites. These findings stress the potential for using 3D-CNNs in detecting neural patterns related to ASD. ZeinabSherkatghanad et al.(24) proposed a solution involving the preprocessing of resting-state fMRI data from the ABIDE I dataset to create functional connectivity matrices that represent correlations between brain regions. They employed a CNN architecture featuring convolutional and densely connected layers to analyze these matrices for Autism Spectrum Disorder (ASD) classification. The model incorporated dropout regularization and was trained using a 10-fold cross-validation strategy, demonstrating effective classification based on dynamic brain connectivity features.
Independent Component Analysis
Independent Component Analysis, is a computational method for separating a multivariate signal into additive independent components. The most important applications are to be found in signal processing and data analysis, such as in blind source separation, where one aims to recover original signals from mixed sources without any previous knowledge. ICA assumes that the visible data is a linear mixture of some independent sources. ICA finds the underlying components by maximizing their statistical independence. ICA has wide applications in neuroimaging, audio, and finance for finding out the hidden factors within complicated datasets. For instance, ICA is able to display separable patterns of brain activity encoded in fMRI data. Mary Beth Nebel et al.(25) proposed a solution to investigate the differences in functional connectivity between autistic children and typically developing children by analyzing resting-state fMRI data.The methodology involves applying Group Independent Component Analysis (ICA) to identify brain networks, followed by constructing partial correlation matrices to explore connectivity patterns while accounting for individual differences and motion artifacts. This approach aims to provide insights into the neurophysiological underpinnings of autism and related conditions.
Elastic Net Regression
Elastic Net is a regularization method that uses both Lasso and Ridge regression penalties on the estimation. It is powerful in models with a lot of features that are correlated. This method includes two additions to the loss function: one is L1 regularization that encourages sparsity by driving some coefficients to zero, plus L2 regularization, which helps to stabilize the estimation and deal with multicollinearity. It allows selecting a subset of variables while preserving model accuracy and interpretability. Elastic Net finds wide applications in genetics, finance, and many other areas that often involve highly correlated predictors. Juntang Zhuang et al.(26) presented feature selection in high-dimensional fMRI data using a two-level modeling approach. This methodology selects important features at the region level to reduce the dimensions through bootstrapped means, followed by voxel-level selection for finer details in modeling.Both Elastic Net Regression and Random Forest are trained independently at these levels. Additionally, visualization techniques are applied to interpret the influence of each variable on predictions, enhancing the predictability and interpretability of the model outputs.
General Linear Model
General Linear Model (GLM) is a conceptual statistical model used to depict the association between a dependent variable and one or more independent variables. In fact, it covers a wide range of statistical models such as linear regression, ANOVA, and ANCOVA that make it flexible enough to analyze continuous, binary, and count data. GLM assumes a linear relationship between dependent and independent variables while allowing the error distributions to vary—normal, binomial, or Poisson—depending upon the nature of the response variable. In GLM, the parameters are estimated by methods such as Ordinary Least Squares for linear regression or Maximum Likelihood Estimation in the case of a non-normal distribution. The coefficients represent the change in the dependent variable for a one-unit change in any independent variable, enabling interpretation of effects associated with the predictors on the response. LluisBorràs-Ferrís et al.(27) utilized resting-state fMRI data from the ABIDE database to analyze functional connectivity differences between individuals with autism and typical controls. The study involved preprocessing steps such as noise removal, brain extraction, and normalization. Full and partial correlation analyses were conducted to evaluate the connections between brain regions, with statistical significance assessed using a general linear model. Two contrasts were tested: one comparing higher connectivity in controls versus individuals with autism, and another examining the opposite. Watson, Benarroch, and Reiss (42) examine neural responses specifically related to direct gaze (DirectGz) versus averted gaze (AvertedGz) stimuli in adolescent boys with fragile X syndrome (fraX). They designed the GLM with a unique "stick function" approach, where each DirectGz repetition (DirectGz-1, DirectGz-2, etc.) was assigned incrementing values to capture neural adaptation or sensitization over repeated exposures and identify regions with altered activation patterns based on the frequency of direct gaze exposure.
Long Short-Term Memory
Long Short-Term Memory networks are a type of RNN elaborated to learn and predict data sequences more effectively by solving the vanishing gradient problem common in traditional RNNs. LSTMs depend on special units, called memory cells, which may keep information for very long time-steps—the key to modeling temporal dependencies in sequences. It is supposed to use the input, forget, and output mechanisms of gating in dealing with the problems posed to it. These are features the models use to keep track and decide what to hang on to and what to let go of, therefore enabling an effective flow of information. LSTMs have recently been widely applied in tasks common in NLP, speech recognition, and time series forecasting since this form of architecture can model complex sequences and temporal patterns. Jianping Qiao et al.(28) came up with a dICA-LSTM framework by integrating individual-level spatial components from rs-fMRI data to construct dFC matrices for classification purposes in disorders like AD and ASD. The framework employs independent component analysis (ICA) for feature extraction, followed by a sliding window approach to create dFC matrices that serve as inputs for an LSTM network. This model aims to leverage temporal information from fMRI data to enhance diagnostic accuracy for these neurological disorders.
Robust Linear Regression Model
Robust linear regression refers to a type of linear regression insensitive to the presence of outliers and violations of assumptions, as compared to its classical form. While methods of ordinary least squares are heavily influenced by outliers, methods of robust linear regression make the model's predictions insensitive to such wild observations. This is done by resorting to other loss functions that are less sensitive to the occurrence of outliers, including Huber loss or quantile loss, which allows for a better adjustment to the majority of points. Some methods, like RANSAC (Random Sample Consensus) or Theil-Sen Estimator, allow one to estimate model parameters by iteratively refining the dataset in order to exclude outliers. In particular, this is useful in fields like finance, medicine, and environmental studies where data can often be filled with abnormalities that make typical linear regressions skew results toward overestimation and provide far more reliable interpretable models. Elizabeth Dryburgh et al.(29) proposed a solution that utilizes multi-site resting-state fMRI data from the ABIDE I dataset to create functional connectivity matrices representing brain connections. The methodology involves extracting significant positive and negative correlations between these brain connections and intelligence scores, followed by the application of a leave-one-out cross-validation strategy to train separate regression models for each group (ASD and neurotypical). These models predict intelligence scores based on summarized connection strengths, facilitating the identification of population-specific biomarkers associated with intelligence.
Connectome-based Predictive Modeling
Connectome-based Predictive Modeling (CPM) is a data-driven approach used in neuroimaging to identify patterns of functional connectivity within the brain that can predict behavioral or clinical outcomes. It analyzes the connectome, which maps neural connections, by examining correlations in brain activity between regions over time. Significant connections, or "edges," are selected based on their ability to distinguish between different groups, and leave-one-out cross-validation is employed to ensure robustness and minimize overfitting. Saggar et al.(30) CPM was used to explore differences in functional connectivity between individuals with Fragile X Syndrome (FXS) and Autism Spectrum Disorder (ASD). Identified specific connectivity patterns that differentiated the groups at baseline, providing insights into unique neural signatures associated with FXS compared to ASD. This application of CPM enhances understanding of the neurobiological mechanisms underlying these disorders and offers potential avenues for targeted interventions.
Linguistic Analysis
Linguistic analysis involves the systematic examination of language use to evaluate various aspects of communication, such as vocabulary richness, fluency, and syntactic complexity. This method provides insights into cognitive and communicative abilities by analyzing how individuals construct their speech. Key measures include lexical diversity, which assesses the range of different words used, and semantic productivity, which evaluates the meaningfulness of the content conveyed. Dysfluencies, such as hesitations or repetitions, can indicate difficulties in language production or cognitive processing. Additionally, researchers may analyze syntactic complexity, focusing on sentence structure and variety, and speech rate, which reflects cognitive processing speed and fluency. Nell Maltmanet al.(31) utilized linguistic analysis by examining transcripts of 5-minute monologues provided by participants with the FMR1 premutation. They assessed various linguistic features, including lexical diversity, semantic productivity, dysfluencies, syntactic complexity, and speech rate, to identify sensitive markers of cognitive decline and their relationship to FXTAS-associated symptoms. By analyzing these features, the study aimed to uncover how language production reflects cognitive functioning in individuals with neurodegenerative conditions. The findings highlighted the importance of language abilities in understanding the cognitive profiles of participants, ultimately contributing to the development of targeted interventions for those affected by FXTAS.
Statistical Parametric Mapping (SPM)
SPM is a software package used for analyzing brain imaging data, especially those from fMRI and PET studies. SPM uses a statistical method that looks at the activation of the brain, allowing researchers to identify regions of the brain that are significantly involved in a particular task or condition. The key concept of SPM is that one statistically models the given data; the parameters of this model are estimated by using GLMs. SPM also offers a variety of correction methods aimed at solving issues such as multiple comparisons, thus providing statistical robustness to the findings. In this connection, SPM was applied to conduct a comprehensive statistical analysis of fMRI data, specifically to test facial emotion processing in patients with FXS. Andrew G. McKechanieet al.(32) designed a matrix weighting for both neutral and fear conditions, enabling second-level analysis using first-level contrast images of each participant. This procedure allows for examination of both in-group and between-group differences in brain activation. The cutoff height threshold was set at p < 0,001 uncorrected, and results were considered significant at the cluster level after FWE correction at p < 0,05. Additionally, age was considered as a covariate to control for confounding effects in the analyses. The SPM analyses helped identify significant patterns of brain activation associated with emotional processing, aiding in a deeper understanding of the neural correlates of autism severity in individuals with FXS. Bruno et al.(44) employed SPM8 for preprocessing fMRI data and analyzing brain activation during a gaze habituation task. They conducted realignment to correct for head movement, motion correction, coregistration of functional and anatomical images, normalization to a standard brain template, and spatial smoothing to enhance image quality.
Protein-Based Assays
Protein-based assays for fragile X syndrome focus on measuring the levels of fragile X mental retardation protein (FMRP), which is the product of the FMR1 gene. These assays assess the percentage of FMRP present in lymphocytes (a type of white blood cell) to determine an individual's affection status for fragile X syndrome. Since individuals with fragile X syndrome typically have reduced or absent levels of FMRP, these assays serve as valuable diagnostic tools. The method can be adapted for various sample types, including lymphocyte, hair root, and prenatal samples, making it versatile for different clinical contexts. By quantifying FMRP levels, clinicians can confirm diagnoses and identify carriers of the FMR1 gene mutation. Crawford DC et al.(35) employed protein-based assays to measure FMRP levels in lymphocytes from participants suspected of having fragile X syndrome. By analyzing these protein levels, they were able to ascertain the affection status of the individuals. The findings demonstrated that individuals with confirmed fragile X syndrome exhibited significantly lower FMRP levels compared to unaffected individuals. This approach not only provided confirmation of diagnoses but also allowed to explore potential correlations between FMRP levels and clinical phenotypes, such as cognitive and behavioral profiles associated with fragile X syndrome. The utility of protein-based assays in enhancing diagnostic accuracy and facilitating early identification of affected individuals, thereby contributing to improved clinical management and intervention strategies for fragile X syndrome.
Voxel-Based Morphometry (VBM)
Voxel-Based Morphometry (VBM) is a neuroimaging analysis technique that focuses on identifying differences in brain structure between groups of individuals by comparing the volume of brain tissue across voxels (three-dimensional pixels) in MRI scans. VBM involves several preprocessing steps, including bias-field correction to reduce intensity non-uniformities in MRI images, segmentation of the brain into different tissue types (gray matter, white matter, and cerebrospinal fluid), spatial normalization to align images to a standard template, and modulation to preserve the original volume of brain tissue during analysis. This approach allows researchers to perform whole-brain analyses and investigate regional brain volume differences between groups. Jennifer L. Bruno (36) applied VBM to analyze structural MRI data from young boys with fragile X syndrome (FXS). The preprocessing steps involved ensuring high-quality images suitable for subsequent statistical comparisons. By using VBM, the authors identified significant differences in gray and white matter volumes between the two clinically distinct subgroups (A and B) identified through Topological Data Analysis (TDA). Specifically, they found that group A exhibited enlarged gray and white matter volumes across multiple brain regions compared to group B. They highlights the neuroanatomical distinctions between the subgroups and contributed to understanding how structural brain differences relate to cognitive, adaptive, and autism-related behaviors in FXS. The VBM analysis provided valuable insights into the underlying neurobiological mechanisms associated with FXS, supporting the overall aim of identifying clinically relevant subtypes within the disorder. Hoeft et al.(39) utilized to examine and differentiate the brain structure of boys with Fragile X Syndrome (FXS) from those who are typically developing (TD) and those with idiopathic developmental delay (DD). The application of VBM allowed the researchers to identify significant differences in gray matter volume across the three groups, enhancing the understanding of how FXS uniquely affects brain structure. By linking these morphometric differences to cognitive and behavioral outcomes, the study provided insights into the neuroanatomical correlates of the cognitive profiles associated with FXS, elucidating the specific challenges faced by individuals with the disorder. Furthermore, the findings underscored the importance of early neuroimaging assessments in identifying brain abnormalities in children with FXS, which could inform targeted interventions. Overall, the use of VBM in this research established a methodological framework for future studies exploring brain structure in FXS and other neurodevelopmental disorders, emphasizing the need for quantitative neuroimaging techniques in understanding the complex relationships between brain morphology and behavioral outcomes.
Neuroconstructivist Model
The neuroconstructivist model posits that cognitive and behavioral development emerges from the interplay of biological, cognitive, and environmental factors throughout an individual’s life. This framework emphasizes that the development of neural systems is influenced not only by genetic predispositions but also by experiential factors and interactions with the environment. In the context of FXS, this model provides a framework for understanding how the genetic mutation at the FMR1 gene resulting in the absence of FMRP interacts with environmental variables and cognitive experiences to yield the distinctive behavioral phenotype of individuals with FXS. Schneider et al.(37) emphasize that cognitive development in FXS arises from the interplay of biological factors, such as the genetic mutation affecting the FMR1 gene, and psychological and environmental influences. They illustrate how these interactions lead to diverse cognitive impairments, including deficits in executive function, attention, and social cognition.
Electrophysiological Techniques
Electrophysiological techniques, particularly electroencephalography (EEG) and event-related potentials (ERPs), are essential tools for studying brain activity and functionality in various neurological and developmental disorders, including Fragile X Syndrome (FXS). These techniques assess the electrical activity of the brain by using electrodes placed on the head, which can record the brain's real-time activity due to specific stimulation. Researchers analyze the pattern of neural oscillations and responses that give signals for abnormal auditory processing, alteration in brain connectivity, and overall neural excitability. These techniques have, therefore, identified key phenotypic markers—apparently increased gamma band power, decreased inter-trial coherence, and impaired habituation to stimuli—which provide clues into the underlying neurophysiology of FXS and suggest potential sites of therapeutic intervention. Razak et al.(38) Application of electrophysiological techniques in advancing our understanding of Fragile X SyndromeThey discuss how EEG and ERP measures have been instrumental in identifying auditory response deficits in both individuals with FXS and Fmr1 knockout mice. These findings underscore the potential of using electrophysiological biomarkers to stratify patients based on neural responses and to predict therapeutic outcomes. Ethridge et al.(47) resting-state electroencephalography (EEG) was applied to investigate neurophysiological differences in individuals with Fragile X Syndrome (FXS) compared to typically developing controls and acquired 5 minutes of continuous EEG data while participants watched a silent video, using a 128-channel electrode net for high spatial resolution. They preprocessed the data to remove artifacts and localized EEG sources using minimum norm estimates, allowing for a more precise analysis of brain activity. By examining power across various frequency bands particularly gamma, theta, and alpha and analyzing cross-frequency coupling, the study identified localized gamma activity increases and pervasive changes in theta/alpha activity.
Authors | Data type | Methods | Accuracy |
|---|---|---|---|
McKechanie et al. | Fmri | (SPM12) | _ |
Mc Devitt et al. | EEG data | (ERP) and (rEEG) | _ |
Lisa B. Wilson et al | MRI | (VBM) | _ |
Fumiko Hoeft et al | MRI | (VBM), (MVPA),(SVM) | 82 % |
Faria Zarin Subah et al. | (ABIDE) | (DNN) classifier | 88 % |
Liu Y et al. | (ABIDE) | (SVM) | 72,2 % |
Schielen S.J.C. et al. | (ABIDE) | (SVM) | 76,0 % |
Hong Li et al. | Fmri | (SVM) | _ |
Karunakaran P et al. | ABIDE | (SVM) and (MSEL) | _ |
X. Yang et al. | ABIDE I | (SVM) | 69,43 % |
Feng Zhao et al. | ABIDE | (SVM) and (LASSO) | 81 % |
Eslami et al. | ABIDE-I | Autoencoder | 82 % |
Fahad Almuqhim and Fahad Saeed | ABIDE | Autoencoder | 70,8 % |
Song et al. | ABIDE | Autoencoder | 74,86 % |
Luo et al. | (fMRI and sMRI) | Polygenic risk score model | 33,33 % |
Zhou Y et al. | Multiparametric MRI | (BayesNet) | 68 % |
N. Chaitra et al. | ABIDE | (RCE-SVM) | 70,01 % |
Taban Eslami et al. | ABIDE | (MLP) | 80 % |
Joseph Stember et al. | ABIDE | DRL | 76 % |
Duan et al. | (ABIDE II) | PCA | 78,6 % |
Rajat Mani Thomas et al. | (ABIDE) I and II | (3D-CNN) | 66 % |
Z. Sherkatghanad et al. | (ABIDE) I | (CNN) | 70,2 % |
M.B. Nebel et al. | rs-fMRI | (DRTMLE) | _ |
Juntang Zhuang et al. | rs-fMRI | elastic net regression | 71 % |
Lluis Borràs-Ferrís et al. | rs-fMRI | General Linear Model | _ |
Jianping Qiao et al. | ADNI and ABIDE | LSTM | _ |
Elizabeth Dryburgh et al. | (ABIDE) I | Robust Linear Regression | _ |
Manish Saggar et al. | rs-fMRI | (CPM) | _ |
Nell Maltman et al. | Language samples | Multivariable linearregressions | _ |
A. G. McKechanie et al. | Facial emotion samples | Fmri | _ |
Knoth, I.S | EEG data | (SVM) | 65,2 % |
Fumiko Hoeft et al. | Neuroimaging data | (SVM) | 90 % |
Dana C. Crawford et al. | Population-based genetic data | DNA-based techniques | 99 % |
Bruno et al. | MRI data | (TDA) | _ |
Hoeft, F et al. | MRI images | VBM | 92,9 % |
Amy S. Garrett et al. | fMRI | (ANOVA) | _ |
Pedapati, E. V., et al. | rs-EEG | EPhys Techniques | _ |
Bruno, J.L. et al. | fMRI | SPM8 | _ |
Feras M. Hantash et al. | Population-based samples | (TrP-PCR) | _ |
The range of studies presented really shows how technology and advanced analytical techniques improve our knowledge of ASD and FXS. Several sources of data, according to table 1, have been used to investigate different, critical aspects of these disorders, including brain structure and functional connectivity, genetics, and behavioral profiles. These findings detail that ASD and FXS are both substantially overlapping and distinct neurobiological and behavioral entities, diagnosis and treatment of which could be complicated. By examining such subtlety, recent research forms the basis for the development of tailored approaches that consider unique and shared elements of each disorder and makes the way to more effective and personalized interventions.This growing body of work serves as an example of the power of interdisciplinary collaboration, weaving neuroimaging with genetics and clinical insights into lucrative early diagnosis, intervention strategies, and improved quality of life for those suffering from such multifarious conditions. The multifaceted focus of table 1 concerns precision as underpinning advances both theoretical and practical in neurodevelopmental disorders.
CONCLUSION
Technological advancements have, therefore, played a very major role in revolutionizing our understanding, diagnosis, and management of the neurodevelopmental disorders—Autism Spectrum Disorder and Fragile X Syndrome. These disorders, although complex and subtle in nature, often manifest themselves through well-specified behavior patterns with minuscule neurological markers that can be quite hard to identify and interpret. But beforehand, breakthroughs in machine learning, genomic sequencing, and neuroimaging ushered in a new era of precision diagnostics, early intervention, and more personalized choices of treatment. Standing at the nexus of the three aforementioned fields—early detection of ASD and FXS—is poised to continue to evolve, holding the great potential to shift life trajectories of individuals afflicted by the disorders.AI-driven tools are identifiers of increasingly critical importance in determining these subtle behavioral and cognitive markers, usually well-hidden from more traditional approaches. Machine learning models, especially those leveraging large and diverse data sources, can now analyze complex neurobiological data for patterns associated with ASD at a high degree of accuracy. These models have helped parse through high-dimensional data from functional Magnetic Resonance Imaging scans in the detection of neuroanatomical variations associated with ASD risk. The early detection enables targeted therapies, adaptive learning interventions, and support systems that could greatly improve the livelihood of those with ASD in building skills—a social interaction, communication, and emotional regulation. Advances in neuroimaging and genetic studies have enabled early diagnosis and personalization of treatment for individuals with FXS. FXS is the most common single-gene cause of ASD because of a mutation of the FMR1 gene that causes intellectual and developmental problems. Advances in genetic testing now allow clinicians to screen for specific mutations associated with FXS, providing an avenue for early diagnosis even before symptoms fully manifest. High-resolution neuroimaging, particularly fMRI, complements genetic assessments by revealing structural and functional abnormalities in the brain associated with FXS. This integrative approach enables clinicians to anticipate developmental and behavioral challenges early on, equipping families and healthcare providers with the information needed to tailor interventions to individual needs. As a result, individuals with FXS can benefit from therapies that are carefully calibrated to their unique neurodevelopmental profiles, ultimately enhancing their quality of life and long-term cognitive outcomes. The future of ASD and FXS diagnostics appears increasingly centered around multimodal, integrated diagnostic frameworks that combine genetic, neuroimaging, and behavioral data. Such frameworks harness the strengths of each modality, with machine learning algorithms synthesizing insights from diverse data sources to provide a holistic view of each individual’s neurodevelopmental profile. This approach aligns closely with the principles of precision medicine, where diagnostic and treatment strategies are customized based on individual variability, ensuring that interventions are not only timely but also specifically tailored to the unique needs of each patient. For instance, AI-driven analysis of genetic and neuroimaging data can help pinpoint precise risk factors and inform the selection of therapies that address both the cognitive and social dimensions of these disorders. By enabling early, personalized care, these tools hold promise for mitigating the impact of ASD and FXS, providing families and clinicians with a powerful resource for managing these conditions more effectively. The rapid progression of these technologies underscores the need for further research and development to realize their full potential. Multidisciplinary collaboration among neuroscientists, geneticists, AI researchers, and clinicians is essential to build robust, scalable models that improve diagnostic accuracy across diverse populations. Investment in these efforts could solidify a foundation for universal, early-access care that adapts to the evolving understanding of ASD and FXS, paving the way for a future where precision medicine for neurodevelopmental disorders is widely accessible. Such advancements will not only transform diagnostic protocols but also enhance support systems, ensuring that individuals with ASD and FXS receive the comprehensive care they need to thrive. Through continued innovation, we edge closer to a healthcare paradigm that prioritizes early intervention, personalized therapies, and holistic support for individuals and families affected by these complex conditions.
References
- 1 McKechanie, A.G., Campbell, S., Eley, S.E., & Stanfield, A.C. (2019). Autism in Fragile X Syndrome; A Functional MRI Study of Facial Emotion Processing. Genes, 10(12), 1052.
- 2 Mc Devitt, N., Gallagher, L., & Reilly, R. B. (2015). Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography—What Can be Interpreted from the Available Information? (2), 92-117.
- 3 Wilson, L. B., Tregellas, J. R., Hagerman, R. J., Rogers, S. J., & Rojas, D. C. (2009). A voxel-based morphometry comparison of regional gray matter between fragile X syndrome and autism. Psychiatry Research: Neuroimaging, 174(2), 138-145.
- 4 Hoeft F, Walter E, Lightbody AA, et al. Neuroanatomical Differences in Toddler Boys With Fragile X Syndrome and Idiopathic Autism. Arch Gen Psychiatry. 2011;68(3):295-305.
- 5 Budimirovic DB, Kaufmann WE. What Can We Learn about Autism from Studying Fragile X Syndrome? Dev Neurosci. 2011;33(5):379-394.
- 6 Subah, F.Z.; Deb, K.; Dhar, P.K.; Koshiba, T. A Deep Learning Approach to Predict Autism Spectrum Disorder Using Multisite Resting-State fMRI. Appl. Sci. 2021,11
- 7 Yaya Liu, Lingyu Xu1, Jun Li2, Jie Yu and Xuan Yu. Attentional Connectivity-based Prediction of Autism Using Heterogeneous rs-fMRI Data from CC200 Atlas. Exp Neurobiol. 2020 Feb;29(1):27-37
- 8 Liu M, Li B and Hu D (2021) Autism Spectrum Disorder Studies Using fMRI Data and Machine Learning: A Review. Front. Neurosci. 15:697870. doi: 10.3389/fnins.2021.697870
- 9 Sjir J. C. Schielen , Jesper Pilmeyer, Albert P. Aldenkamp and Svitlana Zinger. The diagnosis of ASD with MRI: a systematic review and meta-analysis.Translational Psychiatry (2024) 14:318
- 10 Hong Li, Qingqing Zhang, Tao Duan, Jing Li, Lei Shi, Qiang Hua, Dandan Li, Gong‑Jun Ji , Kai Wang &Chunyan Zhu.Sex differences in brain functional specialization and interhemispheric cooperation among children with autism spectrum disorders (2024) 14:22096
- 11 Prof. Sathish, Yasir Babiker Hamdan, Karunakaran P. Early Prediction of Autism Spectrum Disorder by Computational Approaches to fMRI Analysis with Early Learning Technique. Journal of Artificial Intelligence and Capsule Networks (2020) Vol.02/ No.04,207-216,doi.org/10.36548/jaicn.2020.4.003
- 12 Xin Yang, Ning Zhang, PaulSchrader.A study of brain net works for autism spectrum disorder classification using resting state functional connectivity, Machine Learning with Applications 8 (2022)
- 13 Zhao F, Zhang H, Rekik I, An Z and Shen D (2018) Diagnosis of Autism Spectrum Disorders Using Multi-Level High-Order Functional Networks Derived From Resting-State FunctionalMRI. Front. Hum. Neurosci. 12:184. doi: 10.3389/fnhum.2018.00184
- 14 Eslami T, Mirjalili V, Fong A, Laird AR and Saeed F (2019) ASD-DiagNet: A Hybrid Learning Approach for Detection of Autism Spectrum Disorder Using fMRI Data. Front. Neuroinform. 13:70. doi: 10.3389/fninf.2019.00070
- 15 Almuqhim F and Saeed F (2021) ASD-SAENet: A Sparse Autoencoder, and Deep-Neural Network Model for Detecting Autism Spectrum Disorder (ASD) Using fMRI Data. Front. Comput. Neurosci. 15:654315. doi: 10.3389/fncom.2021.654315
- 16 Song Y, Epalle TM and Lu H (2019) Characterizing and Predicting Autism Spectrum Disorder by Performing Resting-State Functional Network Community Pattern Analysis. Front. Hum. Neurosci. 13:203. doi: 10.3389/fnhum.2019.00203
- 17 Luo T, Zhang M, Li S, Situ M, Liu P, Wang M, Tao Y, Zhao S, Wang Z, Yang Y and Huang Y (2024) Exome functional risk score and brain connectivity can predict social adaptability outcome of children with autism spectrum disorder in 4 years’ follow up. Front. Psychiatry 15:1384134. doi: 10.3389/fpsyt.2024.1384134
- 18 Zhou Y, Yu F, Duong T (2014) Multiparametric MRI Characterization and Prediction in Autism Spectrum Disorder Using Graph Theory and Machine Learning. PLoS ONE 9(6): e90405. doi:10.1371/journal.pone.0090405
- 19 N.Chaitra, P.A. Vijaya, Gopikrishna Deshpande.Diagnostic prediction of autism spectrum disorder using complex network measures in a machine learning framework,Biomedical Signal Processing and Control Volume 62, September 2020,doi.org/10.1016/j.bspc.2020.102099
- 20 Taban Eslami, Fahad Saeed. Auto-ASD-Network: A Technique Based on Deep Learning and Support Vector Machines for Diagnosing Autism Spectrum Disorder using fMRI Data, MODI - Machine Learning Models for Multi-omics Data Integration ACM-BCB ’19, September 7–10,2019
- 21 Joseph Stember, Danielle Stember, Luca Pasquini, JenabiMerhnaz, Andrei Holodny and HrithwikShalu.Deepreinforcementlearningfor fMRI predictionofAutismSpectrumDisorder,arXiv:2206.11224v1 [q-bio.NC] 17 Jun 2022
- 22 Duan Y, Zhao W, Luo C, Liu X, Jiang H, Tang Y, Liu C and Yao D (2022) Identifying and Predicting Autism Spectrum Disorder Based on Multi-Site Structural MRI With Machine Learning. Front. Hum. Neurosci. 15:765517. doi: 10.3389/fnhum.2021.765517
- 23 Thomas RM, Gallo S, Cerliani L, Zhutovsky P, El-Gazzar A and van Wingen G (2020) Classifying Autism Spectrum Disorder Using the Temporal Statistics of Resting-State Functional MRI Data With 3D Convolutional Neural Networks. Front. Psychiatry 11:440.doi:10.3389/fpsyt.2020.00440
- 24 Sherkatghanad Z, Akhondzadeh M, Salari S, Zomorodi-Moghadam M, Abdar M, Acharya UR, Khosrowabadi R and Salari V (2020) Automated Detection of Autism Spectrum Disorder Using a Convolutional Neural Network. Front. Neurosci. 13:1325. doi: 10.3389/fnins.2019.01325
- 25 Mary Beth Nebel,DanielE.Lidstone, Liwei Wang,DavidBenkeser,Stewart H. Mostofsky, Benjamin B.Risk.Accounting for motion in resting-state fMRI: What part of the spectrum are we characterizing in autism spectrum disorder? NeuroImage Volume 257, 15 August 2022, 119296
- 26 Juntang Zhuang, Nicha C.Dvornek, Xiaoxiao Li, Pamela Ventola and James S.Duncan.Prediction of Severity and Treatment Outcome for ASD from fMRI
- 27 Lluis Borràs-Ferrís, Úrsula Pérez-Ramírez and David Moratal. Link-Level Functional Connectivity Neuroalterations in Autism Spectrum Disorder: A Developmental Resting-State fMRI Study. Diagnostics 2019, 9, 32; doi:10.3390/diagnostics9010032
- 28 Qiao J, Wang R, Liu H, Xu G and Wang Z(2022) Brain disorder prediction with dynamic multivariate spatio-temporal features: Application to Alzheimer’s disease and autism spectrum disorder. Front. Aging Neurosci. 14:912895. doi: 10.3389/fnagi.2022.912895
- 29 Elizabeth Dryburgh, Stephen McKenna and Islem Rekik. Predicting full-scale and verbal intelligence scores from functional Connectomic data in individuals with autism Spectrum disorder Brain Imaging and Behavior (2020) 14:1769–1778
- 30 Saggar, M., Bruno, J. L., & Hall, S. S. (2023). Brief intensive social gaze training reorganizes functional brain connectivity in boys with fragile X syndrome. Cerebral Cortex, 33(9), 5218–5227.
- 31 Maltman, N. et al. (2024). Language use predicts symptoms of fragile X-associated tremor/ataxia syndrome in men and women with the FMR1 premutation. Scientific Reports, 14, 20707.
- 32 McKechanie, A. G., Campbell, S., Eley, S. E. A., & Stanfield, A. C. (2019). Autism in Fragile X Syndrome; A Functional MRI Study of Facial Emotion-Processing. Genes, 10(12), 1052. 1
- 33 Knoth, I.S., Lajnef, T., Rigoulot, S., Lacourse, K., Vannasing, P., Michaud, J.L., Jacquemont, S., Major, P., Jerbi, K., &Lippé, S. (2018). Auditory repetition suppression alterations in relation to cognitive functioning in fragile X syndrome: a combined EEG and machine learning approach. Journal of Neurodevelopmental Disorders, 10, 4.
- 34 Hoeft, F., Walter, E., Lightbody, A. A., Hazlett, H. C., Chang, C. C., Piven, J., & Reiss, A. L. (2011). Neuroanatomical differences in toddler boys with fragile X syndrome and idiopathic autism. Archives of general psychiatry, 68(3), 295-305.
- 35 Crawford DC, Acuña JM, Sherman SL. FMR1 and the fragile X syndrome: Human genome epidemiology review. Genet Med. 2001;3(5):359-371.
- 36 Bruno, J. L., Romano, D., Mazaika, P., Lightbody, A. A., Hazlett, H. C., Piven, J., & Reiss, A. L. (2017). Longitudinal identification of clinically distinct neurophenotypes in young children with fragile X syndrome. Proceedings of the National Academy of Sciences, 114(40), 10767-10772.
- 37 Schneider, A., Hagerman, R. J., &Hessl, D. (2009). Cognitive profiles in fragile X syndrome. Developmental Disabilities Research Reviews, 15(4), 338-345. 4
- 38 Razak, K. A., Dominick, K. C., & Erickson, C. A. (2020). Developmental studies in Fragile X Syndrome: trends, challenges, and future directions. Journal of Neurodevelopmental Disorders, 12(1), 1-13. 2
- 39 Hoeft, F., Lightbody, A. A., Hazlett, H. C., Patnaik, S., Piven, J., & Reiss, A. L. (2008). Morphometric Spatial Patterns Differentiating Boys With Fragile X Syndrome, Typically Developing Boys, and Developmentally Delayed Boys Aged 1 to 3 Years. Archives of General Psychiatry, 65(9), 1087-1097
- 40 Careaga M, Rose D, Tassone F, Berman RF, Hagerman R, et al. (2014) Immune Dysregulation as a Cause of Autoinflammation in Fragile X Premutation Carriers: Link between FMRI CGG Repeat Number and Decreased Cytokine Responses. PLoS ONE 9(4): e94475.
- 41 Garrett, A. S., Menon, V., MacKenzie, K., & Reiss, A. L. (2004). Here's looking at you, kid: neural systems underlying face and gaze processing in fragile X syndrome. Archives of general psychiatry, 61(3), 281-288.
- 42 Watson, C., Hoeft, F., Garrett, A. S., Hall, S. S., & Reiss, A. L. (2008). Aberrant brain activation during gaze processing in boys with fragile X syndrome. Archives of General Psychiatry, 65(11), 1315-1323.
- 43 Schmitt LM, Shaffer RC, Hessl D, Erickson C. Executive Function in Fragile X Syndrome: A Systematic Review. Brain Sci. 2019 Jan 16;9(1):15.
- 44 Bruno, J. L., Garrett, A. S., Quintin, E. M., Mazaika, P. K., & Reiss, A. L. (2014). Aberrant face and gaze habituation in fragile X syndrome. American Journal of Psychiatry, 171(10), 1099-1106.
- 45 Brunberg, J. A., Jacquemont, S., Hagerman, R. J., Berry-Kravis, E. M., Grigsby, J., Leehey, M. A., ... & Hagerman, P. J. (2002). Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. American Journal of Neuroradiology, 23(10), 1757-1766.
- 46 Hansen, F. S., Canfield, T. K., Lamb, M. Y., Gartler, S. M., & Laird, C. D. (1993). Association of Fragile X Syndrome with Delayed Replication of the FMR1 Gene. Cell, 73(7), 1403-1409.
- 47 Pedapati, E. V., Schmitt, L. M., Ethridge, L. E., Liu, R., Smith, E., Sweeney, J. A., Shaffer, R. C., Dominick, K. C., Gilbert, D. L., Wu, S. W., Horn, P. S., Binder, D., Lamy, M., Axford, M., Miyakoshi, M., & Erickson, C. A. (2022). Neocortical Localization and Thalamocortical Modulation of Neuronal Hyperexcitability in Fragile X Syndrome. medRxiv.
- 48 Schneider, A., Hagerman, R. J., &Hessl, D. (2009). Cognitive profiles in fragile X syndrome. Developmental Disabilities Research Reviews, 15(4), 338-345
- 49 Hantash, F. M., Goos, D. M., Crossley, B., Anderson, B., Zhang, K., Sun, W., & Strom, C. M. (2011). FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genetics in Medicine, 13(1), 39-45.
- 50 Strom, C. M., Huang, D., Li, Y., Hantash, F. M., Rooke, J., Potts, S. J., & Sun, W. (2007). Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome. Genetics in Medicine, 9(4), 199-207.
- 51 Kaufmann, W. E., Cohen, S., Sun, H. T., & Ho, G. (2002). Molecular Phenotype of Fragile X Syndrome: FMRP, FXRPs, and Protein Targets. Microscopy Research and Technique, 57(3), 135-144.
- 52 Morton, N. E., & Macpherson, J. N. (1992). Population genetics of the fragile-X syndrome: Multiallelic model for the FMR1 locus. Proceedings of the National Academy of Sciences, 89(9), 4215-4217.
- 53 Famula, J., Ferrer, E., Hagerman, R. J., Tassone, F., Schneider, A., Rivera, S. M., &Hessl, D. (2022). Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome. Journal of Neurodevelopmental Disorders, 14(1), 1-10
- 54 Scerif, G., Cornish, K., Wilding, J., Driver, J., & Karmiloff-Smith, A. (2007). Delineation of early attentional control difficulties in fragile X syndrome: Focus on neurocomputational changes. Neuropsychologia, 45(9), 1889-1898.
- 55 Kenkel WM, Yee JR, Moore K, Madularu D, Kulkarni P, Gamber K, Nedelman M, Ferris CF. Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit. Translational Psychiatry. 2016;6:e763.
Declarations
Funding
The authors declare that they have not received any funding during the conduct of the research.
Conflict of interest
The authors have no conflicts of interest. AUTHORSHIP CONTRIBUTION Conceptualization: Pavithra D, Smilarubavathy G, Nidhya R. Data curation: Pavithra D, Smilarubavathy G, Nidhya R. Formal analysis: Pavithra D, Smilarubavathy G, Nidhya R. Visualization: Pavithra D, Smilarubavathy G, Nidhya R. Research: Pavithra D, Smilarubavathy G, Nidhya R. Methodology: Pavithra D, Smilarubavathy G, Nidhya R. Project management: Pavithra D, Smilarubavathy G, Nidhya R. Writing - original draft: Pavithra D, Smilarubavathy G, Nidhya R. Writing-proofreading and editing: Pavithra D, Smilarubavathy G, Nidhya R.
Authorship contributions
Drafting – original draft: Pavithra D, Smilarubavathy G, Nidhya R.
Writing–review and editing: Pavithra D, Smilarubavathy G, Nidhya R.